Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Enzo Biochem (ENZ)

Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 65,057
  • Shares Outstanding, K 51,226
  • Annual Sales, $ 31,060 K
  • Annual Income, $ 20,290 K
  • 60-Month Beta 0.75
  • Price/Sales 2.06
  • Price/Cash Flow N/A
  • Price/Book 0.89
Trade ENZ with:

Options Overview Details

View History
  • Implied Volatility 301.87% ( -16.10%)
  • Historical Volatility 31.19%
  • IV Percentile 78%
  • IV Rank 42.44%
  • IV High 682.03% on 12/12/23
  • IV Low 21.58% on 08/14/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 705
  • Open Int (30-Day) 687

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2100 +4.96%
on 03/22/24
1.3800 -7.97%
on 03/04/24
-0.0600 (-4.51%)
since 02/28/24
3-Month
1.2000 +5.83%
on 02/05/24
1.5000 -15.33%
on 01/03/24
-0.1100 (-7.97%)
since 12/28/23
52-Week
1.1600 +9.48%
on 11/10/23
2.7400 -53.65%
on 05/11/23
-1.1600 (-47.74%)
since 03/28/23

Most Recent Stories

More News
Enzo Biochem: Fiscal Q2 Earnings Snapshot

Enzo Biochem: Fiscal Q2 Earnings Snapshot

ENZ : 1.2700 (unch)
Enzo Biochem: Fiscal Q1 Earnings Snapshot

Enzo Biochem: Fiscal Q1 Earnings Snapshot

ENZ : 1.2700 (unch)
Enzo Biochem: Fiscal Q3 Earnings Snapshot

Enzo Biochem: Fiscal Q3 Earnings Snapshot

ENZ : 1.2700 (unch)
SHAREHOLDER ALERT: Weiss Law Investigates Enzo Biochem, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Enzo Biochem, Inc....

ENZ : 1.2700 (unch)
LH : 218.46 (+0.87%)
Enzo Biochem: Fiscal Q2 Earnings Snapshot

Enzo Biochem: Fiscal Q2 Earnings Snapshot

ENZ : 1.2700 (unch)
Stocks Slide Before the Open as First Republic Shares Fall Despite Rescue Deal

June S&P 500 futures (ESM23) are trending down -0.68% this morning after three major U.S. benchmark indices rallied on Thursday as 11 of the nation’s biggest banks injected $30 billion in deposits into...

ESM23 : 4,453.35s (+0.61%)
FRC : 3.51 (-43.30%)
ENZ : 1.2700 (unch)
FDX : 289.74 (+0.65%)
UPS : 148.63 (+0.88%)
NVDA : 903.56 (+0.12%)
X : 40.78 (-0.59%)
SRPT : 129.46 (-0.59%)
WBD : 8.73 (+1.04%)
Enzo Biochem: Fiscal Q1 Earnings Snapshot

Enzo Biochem: Fiscal Q1 Earnings Snapshot

ENZ : 1.2700 (unch)
Enzo Biochem to Launch Monkeypox Testing Services this Week

NEW YORK, NY, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company,...

ENZ : 1.2700 (unch)
Enzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies as Financial Advisor

Third quarter revenue of $26.2 million declined sequentially and year over year due to the anticipated waning of COVID-19 volumes and the economic...

ENZ : 1.2700 (unch)
UPDATE -- Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th

Conference Call and Webcast Scheduled for June 10, 2022, 8:30 am ET...

ENZ : 1.2700 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo...

See More

Key Turning Points

3rd Resistance Point 1.3033
2nd Resistance Point 1.2967
1st Resistance Point 1.2833
Last Price 1.2700
1st Support Level 1.2633
2nd Support Level 1.2567
3rd Support Level 1.2433

See More

52-Week High 2.7400
Fibonacci 61.8% 2.1364
Fibonacci 50% 1.9500
Fibonacci 38.2% 1.7636
Last Price 1.2700
52-Week Low 1.1600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar